Alessia Bari

8PUBLICATIONS

37CO-AUTHORS

Radiation therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Jun 25, 2026

Renoir phase III Rituximab-Lenalidomide vs Rituximab as Maintenance Treatment in Relapsed/Refractory Follicular Lymphoma.

|Mar 19, 2025

Prognostic role of interim PET in follicular lymphoma: a post hoc study of FOLL12 trial by Fondazione Italiana Linfomi.

Rexhep Durmo, Stephane Chauvie, Federico Fallanca

|Dec 11, 2022

Clinical Management of Long-Term Survivors after Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma.

Alessia Bari, Chiara Gerardi, Eleonora Allocati

|May 25, 2022

Anti-CD20 rechallenge with ofatumumab in relapsed/refractory splenic marginal zone lymphoma: the MORE trial.

Lydia Scarfò, Silvia Ferrari, Anna Maria Frustaci

|Feb 15, 2022

Second Cancers in Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma: A Systematic Review by the Fondazione Italiana Linfomi.

Luca Nassi, Vitaliana De Sanctis, Giacomo Loseto

|Oct 13, 2021

Management of Adverse Events and Supportive Therapy in Relapsed/Refractory Multiple Myeloma.

Samantha Pozzi, Alessia Bari, Martin Pecherstorfer

Pageof 2

Frequent Collaborators

3 joint publications

Carla Minoia

1 joint publications

Raffaella Marcheselli

Tamar Tadmor

Stefano Sacchi

Antonella Daniele

Silvia Ferrari

Anna Maria Frustaci

Andrés J M Ferreri

Paolo Ghia

Agata Puzzovivo

Frequent Collaborators

3 joint publications

Carla Minoia

1 joint publications

Raffaella Marcheselli

1 joint publications

Tamar Tadmor

1 joint publications

Stefano Sacchi